Evidence map›Paper›PMID 30060017›Full record

ArticleBrain : a journal of neurology2018

Neurophysiological signatures of Alzheimer's disease and frontotemporal lobar degeneration: pathology versus phenotype.

Saber Sami, Nitin Williams, Laura E Hughes, Thomas E Cope, Timothy Rittman, Ian T S Coyle-Gilchrist, Richard N Henson, James B Rowe

Open access · hybridAbstract read
In one paragraph

Article in Brain : a journal of neurology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 1 pooled it
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 1 synthesis or guideline pooled it, 73 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. GABAergic modulation of beta power enhances motor adaptation in frontotemporal lobar degeneration.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Saber SamiDepartment of Clinical Neurosciences, University of Cambridge, UK.
Nitin WilliamsNeuroscience Center, University of Helsinki, Finland.
Laura E HughesDepartment of Clinical Neurosciences, University of Cambridge, UK.
Thomas E CopeDepartment of Clinical Neurosciences, University of Cambridge, UK.
Timothy RittmanDepartment of Clinical Neurosciences, University of Cambridge, UK.
Ian T S Coyle-GilchristDepartment of Clinical Neurosciences, University of Cambridge, UK.
Richard N HensonMedical Research Council Cognition and Brain Sciences Unit, Cambridge, UK.
James B RoweDepartment of Clinical Neurosciences, University of Cambridge, UK.
University of Cambridge · GBMedical Research Council · GBMRC Cognition and Brain Sciences Unit · GBUniversity of Helsinki · FI

Funding

Medical Research Council G1100464Medical Research Council MC_U105597119Medical Research Council MC_UU_00005/12Medical Research Council MC_UU_00005/8Medical Research Council MR/L023784/1Wellcome Trust 103838
6 · The paper itself

Abstract

The disruption of brain networks is characteristic of neurodegenerative dementias. However, it is controversial whether changes in connectivity reflect only the functional anatomy of disease, with selective vulnerability of brain networks, or the specific neurophysiological consequences of different neuropathologies within brain networks. We proposed that the oscillatory dynamics of cortical circuits reflect the tuning of local neural interactions, such that different pathologies are selective in their impact on the frequency spectrum of oscillations, whereas clinical syndromes reflect the anatomical distribution of pathology and physiological change. To test this hypothesis, we used magnetoencephalography from five patient groups, representing dissociated pathological subtypes and distributions across frontal, parietal and temporal lobes: amnestic Alzheimer's disease, posterior cortical atrophy, and three syndromes associated with frontotemporal lobar degeneration. We measured effective connectivity with graph theory-based measures of local efficiency, using partial directed coherence between sensors. As expected, each disease caused large-scale changes of neurophysiological brain networks, with reductions in local efficiency compared to controls. Critically however, the frequency range of altered connectivity was consistent across clinical syndromes that shared a likely underlying pathology, whilst the localization of changes differed between clinical syndromes. Multivariate pattern analysis of the frequency-specific topographies of local efficiency separated the disorders from each other and from controls (accuracy 62% to 100%, according to the groups' differences in likely pathology and clinical syndrome). The data indicate that magnetoencephalography has the potential to reveal specific changes in neurophysiology resulting from neurodegenerative disease. Our findings confirm that while clinical syndromes have characteristic anatomical patterns of abnormal connectivity that may be identified with other methods like structural brain imaging, the different mechanisms of neurodegeneration also cause characteristic spectral signatures of physiological coupling that are not accessible with structural imaging nor confounded by the neurovascular signalling of functional MRI. We suggest that these spectral characteristics of altered connectivity are the result of differential disruption of neuronal microstructure and synaptic physiology by Alzheimer's disease versus frontotemporal lobar degeneration.

Indexed as

AgedAlzheimer DiseaseBiomarkersBrainConnectomeDiagnostic Techniques, NeurologicalFemaleFrontotemporal DementiaFrontotemporal Lobar DegenerationHumansMagnetic Resonance ImagingMagnetoencephalographyMaleMiddle AgedNerve NetNeurodegenerative DiseasesBiomarkers

Identifiers

PMID30060017
PMCPMC6061803
OpenAlexW2883456549

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.